⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 3, 2024Journal of Geriatric Psychiatry and Neurology

Treatment of Neuropsychiatric Symptoms in Parkinson’s Disease With Botulinum Toxin A: A 12 week Randomized, Double-Blind, Placebo-Controlled Trial

Xiaofeng Zhu Ming Wei Lijun Wang Qiang Tong Xiu Yang Qiu Han

View Full Paper

Ask AI

Bookmark

Share

Abstract

The study aimed to evaluate the impact of Botulinum toxin A (BoNT/A) on neuropsychiatric symptoms in Parkinson's disease (PD) patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhu et al. (2024) studied this question.

synapsesocial.com/papers/68e597e6b6db643587532d57 https://doi.org/10.1177/08919887241281066

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Efficacy of Facial Botulinum Toxin A Injections in Alleviating Neuropsychiatric Symptoms in Parkinson's Disease Patients: An Open-Label, Nonrandomized Controlled Trial.2025
2Therapeutic Botulinum Neurotoxin Ameliorates Motor Deficits and Anxiety, Accompanied by Dopaminergic Neuroprotection and Diminished Microglia Burden in the MPTP-Induced Mouse Model of Parkinson’s Disease2025 · 1 citations
3Botulinum Toxin in Treatments for Abnormal Movements2024
4Botulinum Toxin in Parkinson’s Disease Tremor: A Critical Evaluation of the Evidence and Clinical PracticeLiterature Review · 2026
5Use of botulinum toxin in the management of dystonia in Parkinson’s disease2024 · 5 citations